| Identification | Back Directory | [Name]
5-[[pyridin-3-yl-[3-(trifluoromethyl)phenyl]methylidene]amino]oxypenta noic acid | [CAS]
110140-89-1 | [Synonyms]
R70416
R-70416
R 70416
R-68070
ridogrel
5-[[(E)-(3-Pyridinyl)[3-(trifluoromethyl)phenyl]methylene]aminooxy]valeric acid
5-[[[(E)-α-(Pyridine-3-yl)-3-(trifluoromethyl)benzylidene]amino]oxy]valeric acid
5-[[pyridin-3-yl-[3-(trifluoromethyl)phenyl]methylidene]amino]oxypenta noic acid
Pentanoic acid, 5-[[(E)-[3-pyridinyl[3-(trifluoromethyl)phenyl]methylene]amino]oxy]- | [Molecular Formula]
C18H17F3N2O3 | [MDL Number]
MFCD00873577 | [MOL File]
110140-89-1.mol | [Molecular Weight]
366.33 |
| Chemical Properties | Back Directory | [Melting point ]
70.3° | [Boiling point ]
495.2±55.0 °C(Predicted) | [density ]
1.26±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO: 2mg/mL, clear | [form ]
Solid | [pka]
4.70±0.10(Predicted) | [color ]
White to light yellow |
| Hazard Information | Back Directory | [Uses]
Inhibitor (thromboxane synthetase). | [Uses]
Ridogrel is a dual thromboxane synthase inhibitor and receptor antagonist that may have therapeutic benefits in ulcerative colitis. | [Definition]
ChEBI:Ridogrel is a member of (trifluoromethyl)benzenes. | [Biological Activity]
Ridogrel is an orally activepotent and specific combined thromboxane synthase inhibitor and thromboxane A2 receptor ( thromboxane/prostaglandin endoperoxide receptor) antagonist. Ridogrel is a potent antiplatelet agent. | [IC 50]
EP | [storage]
Store at -20°C |
|
| Company Name: |
Energy Chemical
|
| Telephone: |
400-0056266 |
| Website: |
www.energy-chemical.com |
|